Contract 36E79722A0001
Astellas Pharma Us, Inc. · Department Of Veterans Affairs · September 26, 2024
Astellas Pharma Us, Inc. was awarded a federal contract by Department Of Veterans Affairs on September 26, 2024 for an undisclosed amount of work in pharmaceutical preparation manufacturing. This is a task or delivery order issued under parent IDIQ 36F79721D0260. The contract has been modified 6 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on January 20, 2026. If all options are exercised, the contract could reach $297,000.
Contract details
- PIID
- 36E79722A0001
- Parent IDIQ
- 36F79721D0260
- Award type
- Bpa
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- September 26, 2024
- Latest action
- January 20, 2026
Description
PRICE CHANGE VYLOY
Modification timeline
-
January 20, 2026Mod P00020 · Supplemental Agreement For Work Within Scope$0
-
December 17, 2025Mod P00019 · Supplemental Agreement For Work Within Scope2026 TPR$0
-
December 8, 2025Mod P00018 · Supplemental Agreement For Work Within Scope2026 PUBLIC LAW PRICING UPDATES.$0
-
September 8, 2025Mod P00017 · Exercise An OptionEXERCISE 4TH OPTION YEAR$0
-
July 9, 2025Mod P00016 · Supplemental Agreement For Work Within ScopeZYLOY PRICE CHANGE$0
-
February 26, 2025Mod P00014$0
-
September 26, 2024Mod P00009 · Exercise An OptionEXERCISE OPTION YEAR 3$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36E79722A0001?
Contract 36E79722A0001 is a federal contract awarded to Astellas Pharma Us, Inc. by Department Of Veterans Affairs on September 26, 2024 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 6 times since the base award.
Who won contract 36E79722A0001?
Astellas Pharma Us, Inc. won contract 36E79722A0001 from Department Of Veterans Affairs.
How much is contract 36E79722A0001 worth?
Contract 36E79722A0001 has obligated $0 to date but carries a potential ceiling of $297,000 if fully funded and all options are exercised.